Compare HLLY & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HLLY | EMBC |
|---|---|---|
| Founded | 1903 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 277.6M | 328.1M |
| IPO Year | 2020 | 2021 |
| Metric | HLLY | EMBC |
|---|---|---|
| Price | $2.57 | $6.80 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 4 |
| Target Price | ★ $4.58 | $4.00 |
| AVG Volume (30 Days) | ★ 1.0M | 827.1K |
| Earning Date | 11-06-2026 | 11-24-2026 |
| Dividend Yield | N/A | ★ 0.60% |
| EPS Growth | ★ 180.00 | 20.90 |
| EPS | 0.04 | ★ 1.03 |
| Revenue | ★ $613,514,000.00 | N/A |
| Revenue This Year | $1.84 | N/A |
| Revenue Next Year | $4.33 | $5.59 |
| P/E Ratio | $62.00 | ★ $6.48 |
| Revenue Growth | ★ 1.87 | N/A |
| 52 Week Low | $2.25 | $2.77 |
| 52 Week High | $4.48 | $14.91 |
| Indicator | HLLY | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 51.63 | 71.98 |
| Support Level | $2.52 | $3.01 |
| Resistance Level | $2.66 | $9.38 |
| Average True Range (ATR) | 0.12 | 0.30 |
| MACD | 0.03 | 0.05 |
| Stochastic Oscillator | 66.30 | 91.39 |
Holley Inc designs, manufactures, and distributes high-performance automotive aftermarket products to car and truck enthusiasts in the United States, Canada and Europe. It manufactures a diversified line of performance automotive products, including carburetors, fuel pumps, fuel injection systems, nitrous oxide injection systems, superchargers, exhaust headers, mufflers, distributors, ignition components, engine tuners and automotive performance plumbing products. It also manufactures exhaust products as well as shifters, converters, transmission kits, transmissions, tuners and automotive software. The company markets its products under brands such as Holley, Holley EFI, MSD, Simpson, Flowmaster, EDGE, Cataclean, and Accel, among others. It operates in single segment.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.